Madrigal Pharmaceuticals (MDGL) PT Raised to $375 at Oppenheimer
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $527.95 -0.22%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 9 | New: 41
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 9 | New: 41
Join SI Premium – FREE
Oppenheimer analyst Jay Olson raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $375.00 (from $320.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$236 at Bernstein SocGen Group
- Amgen (AMGN) PT Lowered to $430 at UBS
- Cargojet Inc. (CJT:CN) (CGGJF) PT Raised to $128 at TD Cowen, maintains bullish call
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
